Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_assertion type Assertion NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_head.
- NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_assertion description "[To assess a possible role in tumor progression, the occurrence and type of K- and N-RAS mutations were determined in purified tumor cells, including samples from patients with premalignant monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and extramedullary plasma cell (PC) tumors (ExPCTs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_provenance.
- NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_assertion evidence source_evidence_literature NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_provenance.
- NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_assertion SIO_000772 15339850 NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_provenance.
- NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_assertion wasDerivedFrom befree-20140225 NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_provenance.
- NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_assertion wasGeneratedBy ECO_0000203 NP643671.RAbwgntaLFo8oQcQFMImpwzfKNYfNRC5H14LER2z6LX44130_provenance.